Halozyme Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HALO and other ETFs, options, and stocks.About HALO
Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence.
CEOHelen I. Torley
CEOHelen I. Torley
Employees350
Employees350
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1998
Founded1998
Employees350
Employees350
HALO Key Statistics
Market cap7.04B
Market cap7.04B
Price-Earnings ratio15.16
Price-Earnings ratio15.16
Dividend yield—
Dividend yield—
Average volume3.87M
Average volume3.87M
High today$57.95
High today$57.95
Low today$56.79
Low today$56.79
Open price$57.48
Open price$57.48
Volume1.21M
Volume1.21M
52 Week high$70.51
52 Week high$70.51
52 Week low$42.01
52 Week low$42.01
Analyst ratings
50%
of 10 ratingsBuy
50%
Hold
40%
Sell
10%
People also own
Based on the portfolios of people who own HALO. This list is generated using Robinhood data, and it’s not a recommendation.